CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Top Biotech Industry Trends to Watch for in 2022

Top Biotech Industry Trends to Watch...

Encore Healthcare's VP of Clinical Operations Carrie Hylton-Proffitt, RRT Earns Accreditation with ACHC

Encore Healthcare's VP of Clinical...

Challenges Facing Biotech Companies Seeking Funding

Challenges Facing Biotech Companies...

How are Advancements in Biotechnology Help People Improve their Lives?

How are Advancements in Biotechnology...

Key Trends in Bioengineering to Watch for in 2022

Key Trends in Bioengineering to Watch...

How AI is Reshaping the Biotechnology Sector

How AI is Reshaping the Biotechnology...

Gene Mack Positioned as the Chief Financial Officer at Imcyse

Gene Mack Positioned as the Chief...

The Use of Artificial Intelligence in the Biotechnology

The Use of Artificial Intelligence in...

Top Biotech Industry Trends to Watch for in 2022

Top Biotech Industry Trends to Watch...

Encore Healthcare's VP of Clinical Operations Carrie Hylton-Proffitt, RRT Earns Accreditation with ACHC

Encore Healthcare's VP of Clinical...

Challenges Facing Biotech Companies Seeking Funding

Challenges Facing Biotech Companies...

How are Advancements in Biotechnology Help People Improve their Lives?

How are Advancements in Biotechnology...

Key Trends in Bioengineering to Watch for in 2022

Key Trends in Bioengineering to Watch...

How AI is Reshaping the Biotechnology Sector

How AI is Reshaping the Biotechnology...

Gene Mack Positioned as the Chief Financial Officer at Imcyse

Gene Mack Positioned as the Chief...

The Use of Artificial Intelligence in the Biotechnology

The Use of Artificial Intelligence in...

Dr. Soren Thestrup-Nielsen M.D Joins Mainz Biomed's Strategic Advisory Board

Life Sciences Review Life Sciences Review | Friday, December 03, 2021
Tweet

As a member of the Strategic Advisory Board, Dr. Soren Thestrup-Nielsen will participate actively in the company’s product development and commercial strategies.


Fremont, CA: "It's a pleasure to welcome Soren to our newly formed Strategic Advisory Board as he brings us tremendous leadership in all aspects of a product's life cycle, commented Guido Baechler, Chief Executive Officer of Mainz Biomed. Dr. Soren Thestrup-Nielsen M.D. has joined the Strategic Advisory Board of Mainz Biomed N.V., a molecular genetics diagnostic company focusing on early cancer detection.  "All of us at the company are excited to work with Soren as we embark on ColoAlerts commercial roll-out across Europe and develop the regulatory and clinical strategy for the U.S. market." added, Baechler.


Dr. Thestrup-Nielsen has worked in the medical device sector for over 25 years, first at Boston Scientific and then at Danaher Corporation, where he supervised Danaher's acute care and laboratory diagnostics portfolio's inorganic growth.


He has held a number of notable executive positions in the past, including Chairman of Althea Group and member of the board of directors of a number of firms, including lung cancer screening startup Oncimmune. Dr. Thestrup-Nielsen has worked with medical enterprises in both North America and Europe on IPOs, trade sales, acquisitions, and a range of investment transactions. He earned his M.D. from the University of Copenhagen School of Medicine, worked as a general and vascular surgeon for five years, and earned an MBA from the IMD in Lausanne, Switzerland.


Dr. Thestrup-Nielsen will play an active part in the creation of the Company's product strategy for Europe, the United States, and the rest of the world, including clinical development, market segmentation, go-to-market strategy, and regulatory strategy, in his advisory capacity with Mainz Biomed. He'll also advise on the creation of the worldwide commercial strategy and the clinical plan for future versions of Mainz Biomeds' ColoAlert test, as well as lead the clinical advisor's board once it's established.


Weekly Brief

loading
Top 10 Biotech Startups Companies - 2022
> <
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue

Read Also

Role of Predictive Genomics in Sustainable Healthcare

Role of Predictive Genomics in Sustainable Healthcare

A Conversational AI Approach to Regulatory Intelligence

A Conversational AI Approach to Regulatory Intelligence

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is expected in coming years

Omniabio Inc. Announces Private Investor

Omniabio Inc. Announces Private Investor
Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Lithuania's Vision to Become a Biotech Hub in Europe

Lithuania's Vision to Become a Biotech Hub in Europe

Bridging the Diversity Gap in Genomics

Bridging the Diversity Gap in Genomics

How does Biotechnology Provide Solutions to Human Needs?

How does Biotechnology Provide Solutions to Human Needs?
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/dr-soren-thestrupnielsen-md-joins-mainz-biomed-s-strategic-advisory-board-nwid-656.html